Gene · 2012
Papers1,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Talent management practices and other factors affecting employee performance in the public healthcare sector in poland: an empirical study using structural equation modelling. | BMC Health Serv Res | 2024 | 39736617 | PubTator, text mining | PubMed |
| Protein level of epithelial membrane protein (EMP) 1, EMP 2, and EMP 3 in carcinoma of unknown primary. | Neoplasma | 2024 | 39556425 | PubTator, text mining | PubMed |
| Unveiling miRNA-Gene Regulatory Axes as Promising Biomarkers for Liver Cirrhosis and Hepatocellular Carcinoma. | ACS Omega | 2024 | 39524633 | PubTator, text mining | PubMed |
| A new trial monitoring plan (TMP) template for clinical trials: output from a Delphi process. | Trials | 2024 | 39516824 | PubTator, text mining | PubMed |
| Epithelial membrane protein 1 in human cancer: a potential diagnostic biomarker and therapeutic target. | Biomark Med | 2024 | 39469853 | PubTator, text mining | PubMed |
| Unveiling the promise: Exosomes as game-changers in anti-infective therapy. | Exploration (Beijing) | 2024 | 39439498 | PubTator, text mining | PubMed |
| Nanoenergetic Materials: From Materials to Applications. | Nanomaterials (Basel) | 2024 | 39404301 | PubTator, text mining | PubMed |
| Construction and validation of a prognostic model of angiogenesis-related genes in multiple myeloma. | BMC Cancer | 2024 | 39394121 | PubTator, text mining | PubMed |
| A modified model of PANoptosisto identify prognosis and immunotherapy response in bladder cancer. | Int J Biochem Cell Biol | 2024 | 39368544 | PubTator, text mining | PubMed |
| EMP3: A promising biomarker for tumor prognosis and targeted cancer therapy. | Cancer Biomark | 2024 | 39213053 | PubTator, text mining | PubMed |
| Differential effects of enzymatically modified Ougan (Citrus Suavissima Hort. ex Tanaka) peel pectins extracted with different methods on inhibiting the proliferation of Hela cells. | Int J Biol Macromol | 2024 | 39102920 | PubTator, text mining | PubMed |
| An Apoptosis-Related Specific Risk Model for Breast Cancer: From Genomic Analysis to Precision Medicine. | Front Biosci (Landmark Ed) | 2024 | 39082332 | PubTator, text mining | PubMed |
| Key Component Analysis of the Time Toxicity Interaction of Five Antibiotics to Q67. | Toxics | 2024 | 39058173 | PubTator, text mining | PubMed |
| Terahertz Fingerprint Metasurface Sensor Based on Temperature Variation for Trace Molecules. | Biosensors (Basel) | 2024 | 39056594 | PubTator, text mining | PubMed |
| Monocyte Transcriptome in Different Phases of Chronic Hepatitis B Virus Infection Uncovers Potential Functional Roles. | Viral Immunol | 2024 | 39049796 | PubTator, text mining | PubMed |
| Integrating single-cell RNA-seq to identify fibroblast-based molecular subtypes for predicting prognosis and therapeutic response in bladder cancer. | Aging (Albany NY) | 2024 | 39033778 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients. | J Transl Med | 2024 | 38937754 | PubTator, text mining | PubMed |
| Modal Parameter Recursive Estimation of Concrete Arch Dams under Seismic Loading Using an Adaptive Recursive Subspace Method. | Sensors (Basel) | 2024 | 38931630 | PubTator, text mining | PubMed |
| Integrated analysis of colorectal cancer metastasis identifies characteristics of tumor cell during metastasis. | Gastroenterol Rep (Oxf) | 2024 | 38818308 | PubTator, text mining | PubMed |
| Time management practice and associated factors among health professionals working in public and private hospitals in Dessie City, Northeast Ethiopia: a comparative cross-sectional study. | Front Psychol | 2024 | 38751768 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2012/papers?page=6